Loading cancer entity…
Loading cancer entity…
Clinical trials
22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04255576 | Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone | unknown | Phase 1 / Phase 2 | 139 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Oct 14, 2022 | clinicaltrials |
| NCT03358212 | Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China | unknown | — | 100 | Peking University People's HospitalOTHER | 0 | Nov 30, 2017 | clinicaltrials |
| NCT03259152 | Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone(D-Gct) | unknown | Phase 3 | 30 | Hebei Medical University Third HospitalOTHER | 1 | Aug 24, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Oct 14, 2022source: clinicaltrials